# Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection

Study · id `cardio:ct-nct04850417` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04850417](<https://clinicaltrials.gov/study/NCT04850417>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04850417

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT04850417. Randomized; single masking; primary purpose treatment. Start 2021-04-30 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT04850417, source copy `cardio:ctgov-nct04850417-2021-04-20`, retrieved 2026-10-26)
- Planned start: 2021-04-30 (anticipated) (ClinicalTrials.gov record NCT04850417, source copy `cardio:ctgov-nct04850417-2021-04-20`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT04850417, source copy `cardio:ctgov-nct04850417-2021-04-20`, retrieved 2026-10-26)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT04850417, source copy `cardio:ctgov-nct04850417-2021-04-20`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04850417-2021-04-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection
- Acronym: BA-SCAD
- Condition: Spontaneous Coronary Artery Dissection
- Intervention (Drug): Beta blocker, aspirin, clopidogrel
- Lead sponsor: Spanish Society of Cardiology
- Lead sponsor class: OTHER
- Collaborator: Instituto de Investigación Sanitaria Hospital Universitario de la Princesa
- Collaborator class: OTHER
- Collaborator: Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Spanish Society of Cardiology (`cardio:org-spanish-society-of-cardiology`)

## Provenance

Content hash: 800ea911b42da6baefd3443382ce527c826b780def18b99a7e09b1735519d9ab
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
